Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells
Jessika Bertacchini, Chiara Frasson, Francesca Chiarini, et al.
Advances in Biological Regulation (2018) Vol. 68, pp. 2-9
Closed Access | Times Cited: 20

Showing 20 citing articles:

Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease
Manoj K Rathinaswamy, John E. Burke
Advances in Biological Regulation (2019) Vol. 75, pp. 100657-100657
Closed Access | Times Cited: 95
Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence
Salihanur Darici, Hazem Alkhaldi, Gillian Horne, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2934-2934
Open Access | Times Cited: 85
Small-Molecule Fms-like Tyrosine Kinase 3 Inhibitors: An Attractive and Efficient Method for the Treatment of Acute Myeloid Leukemia
Yue Zhong, Runze Qiu, Shan‐Liang Sun, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12403-12428
Closed Access | Times Cited: 70
Cell signaling and cancer: a mechanistic insight into drug resistance
Munmun Panda, Bijesh K. Biswal
Molecular Biology Reports (2019) Vol. 46, Iss. 5, pp. 5645-5659
Closed Access | Times Cited: 73
Phosphoinositide 3 Kinase Signaling in Human Stem Cells from Reprogramming to Differentiation: A Tale in Cytoplasmic and Nuclear Compartments
Giulia Ramazzotti, Stefano Ratti, Roberta Fiume, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 2026-2026
Open Access | Times Cited: 34
Upstream regulators of phosphoinositide 3‐kinase and their role in diseases
Dandan Wang, Weijie Zhou, Jingyu Chen, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 9, pp. 14460-14472
Closed Access | Times Cited: 25
PD‑L1 promotes head and neck squamous cell carcinoma cell growth through mTOR signaling
Anyuan Zheng, Fen Li, Fuhai Chen, et al.
Oncology Reports (2019)
Open Access | Times Cited: 25
Integrative genomic analysis of a novel small nucleolar RNAs prognostic signature in patients with acute myelocytic leukemia
Rui Huang, Xiwen Liao, Qiaochuan Li
Mathematical Biosciences & Engineering (2022) Vol. 19, Iss. 3, pp. 2424-2452
Open Access | Times Cited: 9
Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways
Lubomír Minařík, Kristýna Pimková, Juraj Kokavec, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 223-223
Open Access | Times Cited: 8
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes
Jie Xian, Eric Owusu Obeng, Stefano Ratti, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 697-697
Open Access | Times Cited: 12
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells
Salihanur Darici, Manuela Zavatti, Luca Braglia, et al.
Advances in Biological Regulation (2021) Vol. 82, pp. 100830-100830
Open Access | Times Cited: 11
Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG)
Bożena Katarzyna Budziszewska, Aleksander Salomon‐Perzyński, Katarzyna Pruszczyk, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4189-4189
Open Access | Times Cited: 9
The clinical significance of CDX2 in leukemia: A new perspective for leukemia research
Mina Darvishi, Pargol Mashati, Abbas Khosravi
Leukemia Research (2018) Vol. 72, pp. 45-51
Closed Access | Times Cited: 6
Circulating miR-126-3p and miR-423-5p Expression in de novo Adult Acute Myeloid Leukemia: Correlations with Response to Induction Therapy and the 2-Year Overall Survival
Faez Almohsen, Haithem Ahmed Al-Rubaie, Manal A. Habib, et al.
Journal of Blood Medicine (2022) Vol. Volume 13, pp. 83-92
Open Access | Times Cited: 4
Strategies for the treatment of acute myeloid leukemia with FLT3 mutations: a patent review
Lukáš Górecki, Eva Řezníčková, Vladimı́r Kryštof, et al.
Expert Opinion on Therapeutic Patents (2024), pp. 1-28
Closed Access
Dual Kinase Targeting in Leukemia
Luca Mologni, Giovanni Marzaro, Sara Redaelli, et al.
Cancers (2021) Vol. 13, Iss. 1, pp. 119-119
Open Access | Times Cited: 2

Sandhya Jain, Surya Prakash Gupta
International Journal of Pharmaceutical Sciences and Research (2023) Vol. 14, Iss. 9
Open Access
Targeting the phosphatidylinositol 3-kinase signaling pathway in acute myeloid leukemia
Ota Fuchs
Integrative Cancer Science and Therapeutics (2020) Vol. 7, Iss. 4
Open Access
Identification of a novel small nucleolar RNAs prognostic signature for patients with acute myelocytic leukemia
Rui Huang, Xiwen Liao, Qiaochuan Li
Research Square (Research Square) (2020)
Open Access
Mechanisms Involved in the Promoting Activity of Fibroblasts in HTLV-1-Mediated Lymphomagenesis: Insights into the Plasticity of Lymphomatous Cells
Giulia Rigotto, Barbara Montini, Adriana Mattiolo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10562-10562
Open Access
Page 1

Scroll to top